Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2007
01/25/2007WO2007010219A2 Methods for modulating a wnk i soform protein kinase activity
01/25/2007WO2007010110A2 Method for detecting aggregate-forming circulating protein forms and agent for capturing formed aggregates
01/25/2007WO2007010089A2 Cancer specific glycans and use thereof
01/25/2007WO2007010076A1 Semi-insulating silicon carbide (sic) sensor system, production method thereof and use of same
01/25/2007WO2007009994A1 Support having nanostructured titanium dioxide film and uses thereof
01/25/2007WO2007009948A1 Method for the simultaneous detection of a plurality of different types of atmospheric pollution using gas-sensitive field effect transistors
01/25/2007WO2007009816A2 Plexin d1 as a target for tumor diagnosis and therapy
01/25/2007WO2007009789A1 Csf diagnostic in vitro method for diagnosis of dementia and neuroinflammatory diseases
01/25/2007WO2007009727A1 Method for the identification of proteins folding inhibitors
01/25/2007WO2007009613A1 Method for measuring tyrosine kinase phosphorylation
01/25/2007WO2007009554A1 Method and device for investigating a mineral sample
01/25/2007WO2007009519A1 Device for affinity separating by means of magnetic particles
01/25/2007WO2007009469A2 Potency assays for antibody drug substance binding to an fc receptor
01/25/2007WO2007009457A2 Identification of protein ligands modifying a cellular response
01/25/2007WO2007009356A1 A method for detecting and culturing pancreatic cells and their application
01/25/2007WO2007009194A1 Sra binding protein
01/25/2007WO2006131013A3 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα
01/25/2007WO2006130022A8 Modulation of ovulation by agonists and antagonists of bmprii
01/25/2007WO2006122986A3 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
01/25/2007WO2006121799A3 Liquid crystal based analyte detection
01/25/2007WO2006117689A3 Method for diagnosing multiple sclerosis
01/25/2007WO2006116075A3 Methods and compositions for inhibiting hiv infection using agents that modulate isopeptidase t activity
01/25/2007WO2006114097A3 Biosurface structure array
01/25/2007WO2006113865A3 Auto-calibration label and method of forming the same
01/25/2007WO2006113840A3 Method of forming an auto-calibration label using a laser
01/25/2007WO2006111550A3 Method using an electrochemical sensor and electrodes forming said sensor
01/25/2007WO2006100388A3 Cholesterol-mimetic pyrene probes
01/25/2007WO2006099549A3 Filtration tester and method for predicting to which extent a printing ink would lead to a clogging of a printer nozzle
01/25/2007WO2006099185A3 Brsk1s as modifiers of the pten/akt pathway and methods of use
01/25/2007WO2006099183A3 Nek8s as modifiers of the pten/akt pathway and methods of use
01/25/2007WO2006093797A3 Method and kit for detecting porcine reproductive and respiratory syndrome virus
01/25/2007WO2006088771A3 Apparatus and methods for analyzing body fluid samples
01/25/2007WO2006067063A3 Screening methods for identification of modulators of cytokine class i
01/25/2007WO2006053125A3 Gp201: methods and compositions for treating cancer
01/25/2007WO2006050945A3 Tubulin mutation diagnostic
01/25/2007WO2006039238A3 Irta2 antibodies and methods of use
01/25/2007WO2006037048A3 Fc RECEPTOR HOMOLOG ANTIBODIES AND USES THEREOF
01/25/2007WO2006031607A3 A method of treating cancer
01/25/2007WO2006023229A3 Treatment of epilepsy by expressing st3gal-iii
01/25/2007WO2006008633A3 Receptor protein tyrosine phosphatase gamma (ptprg) as marker for dendritic cells cells
01/25/2007WO2005114210A8 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 3 (grk3)
01/25/2007WO2005086773A3 A method for delivering therapeutic proteins to the intradermal compartment
01/25/2007WO2005081982A3 Methods for preparing t-cells for cell therapy
01/25/2007WO2005057172A3 Identification, isolation and elimination of cancer stem cells
01/25/2007WO2005043157A3 Optical detector of organic analyte
01/25/2007WO2004108065A3 Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies
01/25/2007WO2004104549A3 Identification and quantification of organ-specific proteins derived from human allogeneic cells using proteomics
01/25/2007WO2004063337A3 Kunitz domain library
01/25/2007WO2004058797A3 Human monoclonal antibodies against interleukin 8 (il-8)
01/25/2007WO2004046155A3 Predicting outcome of hyperbaric oxygen therapy treatment with nitric oxide bioavailability
01/25/2007US20070021926 Method and system for designing proteins and protein backbone configurations
01/25/2007US20070021918 Universal gene chip for high throughput chemogenomic analysis
01/25/2007US20070021805 Biocompatible sensor electrode assembly and method for the production thereof
01/25/2007US20070021684 Tissue punching device
01/25/2007US20070021602 High density, miniaturized arrays and methods of manufacturing same
01/25/2007US20070021599 Comprises transport proteins diagnosis and treatment of cell proliferative disorders; antiproliferative agents; gene expression inhibition; detecting differential methylation patterns in the SLC5A8 gene which encode novel sodium solute symporter members
01/25/2007US20070021592 NPC1L1 (NPC3) and methods of use thereof
01/25/2007US20070021496 Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
01/25/2007US20070021378 Heparin compositions and selectin inhibition
01/25/2007US20070021348 Novel treatment
01/25/2007US20070021332 Helminth-derived antigens having capacity of providing protection against parasites
01/25/2007US20070021321 determining whether catechin or an antibody has the same pharmacological effect as that of epigallocatechin gallate, on inhibiting cell proliferation, angiogenesis or cancer cell metastasis, as a neuroprotectant, a viricide, an antiallergen and as a antiarteriosclerotic agent
01/25/2007US20070020770 MEMS-based integrated magnetic particle identification system
01/25/2007US20070020769 immunochemical ligand-receptor reactions and specially selected, treated, and arranged filter material; Bioassay utilizes cardiac troponin I to detect, stratify and predict mortality in patients
01/25/2007US20070020768 Two step lateral flow assay methods and devices
01/25/2007US20070020766 Diagnosis of pre-eclampsia
01/25/2007US20070020765 Procedure for the standardization of coagulation tests
01/25/2007US20070020762 Methods for Determining Corrosion Products on Substrates Using Infrared Imaging
01/25/2007US20070020754 Cell handling device, human tissue regeneration composition, and human tissue regeneration method
01/25/2007US20070020749 Materials and methods for creating imaging layers
01/25/2007US20070020745 Method for crystallizing human GSK3 and novel crystal structure thereof
01/25/2007US20070020743 Undecaprenyl pyrophosphate synthase (upps)enzyme and methods of use
01/25/2007US20070020733 Polypeptide for use in the diagnosis and detection of bacterial infections
01/25/2007US20070020732 Inflammatory response protein for use in developing vaccines against allergic diseases; allergic response modulation; antiallergens; signal transducer specifically expressed in human mast cells
01/25/2007US20070020713 Antibodies to the fuel oxygenate mtbe and use thereof in immunoassays
01/25/2007US20070020712 Contacting the test compound with polypeptide; detecting binding of the test compound with the polypeptide, wherein binding indicates that the test compound is a candidate antibacterial agent
01/25/2007US20070020711 Fungal antigen immunoassay
01/25/2007US20070020710 Antibodies that spefically recognize inactive PSA, and uses thereof
01/25/2007US20070020709 IGF binding proteins
01/25/2007US20070020708 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition
01/25/2007US20070020707 Using collagenase binding protein concentrations as evaluative tool in diagnosing/prediciting cell proliferative disorders
01/25/2007US20070020706 Truncated proteins as cancer markers
01/25/2007US20070020705 placental leucine aminopeptidase (P-LAP); cell surface aminopeptidase, oxytocinase, insulin-regulated membrane aminopeptidase associated with glucose transporter; ovarian cancer; polyclonaly antibodies
01/25/2007US20070020704 Diaryl ureas with kinase inhibiting activity
01/25/2007US20070020703 Use of compositions comprising a soluble form of hla-g in the treatment of blood diseases
01/25/2007US20070020701 Magnetic resonance system and method to detect and confirm analytes
01/25/2007US20070020700 Lateral flow assay and device using magnetic particles
01/25/2007US20070020699 Lateral flow assay and device using magnetic particles
01/25/2007US20070020698 IGF binding proteins
01/25/2007US20070020697 Virtual flow cytometry on immunostained tissue-tissue cytometer
01/25/2007US20070020696 Appl proteins as rab5 effectors
01/25/2007US20070020695 Immunogenic peptide sequences; antibodies directed against particular amino acid regions of Hsp70B'
01/25/2007US20070020694 Linking oligopeptide to a stabilizing group, linking the oligopeptide to a therapeutic agent, testing if the conjugate is cleavable by Thimet oligopeptidase
01/25/2007US20070020693 Devices and methods for pharmacokinetic-based cell culture system
01/25/2007US20070020692 Methods of assaying connective tissue growth factor
01/25/2007US20070020691 Multiplex determination of lipid specific binding moieties
01/25/2007US20070020690 Method for site-specific protein modifications
01/25/2007US20070020689 Label-free high throughput biomolecular screening system and method
01/25/2007US20070020688 Measurement method using biosensor
01/25/2007US20070020687 Detection of rho proteins